BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $675,761 | -13.0% | 17,906 | +5.1% | 0.02% | -11.8% |
| Q2 2023 | $776,295 | +19.4% | 17,039 | +6.3% | 0.02% | +6.2% |
| Q1 2023 | $649,995 | -21.6% | 16,026 | -11.7% | 0.02% | -30.4% |
| Q4 2022 | $829,582 | -5.3% | 18,157 | +11.6% | 0.02% | -30.3% |
| Q3 2022 | $876,000 | -8.5% | 16,264 | +9.2% | 0.03% | 0.0% |
| Q2 2022 | $957,000 | -14.7% | 14,900 | +3.0% | 0.03% | -25.0% |
| Q1 2022 | $1,122,000 | -15.3% | 14,470 | -6.3% | 0.04% | -18.5% |
| Q4 2021 | $1,325,000 | +7.4% | 15,436 | +0.6% | 0.05% | -5.3% |
| Q3 2021 | $1,234,000 | -86.2% | 15,343 | -86.2% | 0.06% | -86.2% |
| Q2 2021 | $8,961,000 | -4.8% | 111,317 | -0.2% | 0.41% | -17.1% |
| Q1 2021 | $9,411,000 | +14.5% | 111,584 | +8.9% | 0.50% | -15.7% |
| Q4 2020 | $8,221,000 | +1.2% | 102,455 | +1.5% | 0.59% | -16.4% |
| Q3 2020 | $8,120,000 | -57.7% | 100,970 | -54.7% | 0.71% | -61.2% |
| Q2 2020 | $19,211,000 | +6.0% | 223,124 | -0.1% | 1.82% | -3.3% |
| Q1 2020 | $18,126,000 | -2.8% | 223,254 | +0.1% | 1.89% | +20.5% |
| Q4 2019 | $18,652,000 | +80.9% | 223,057 | +89.2% | 1.56% | +62.3% |
| Q3 2019 | $10,313,000 | +7.0% | 117,903 | +0.2% | 0.96% | +1.5% |
| Q2 2019 | $9,640,000 | +0.8% | 117,705 | +0.1% | 0.95% | -4.9% |
| Q1 2019 | $9,562,000 | +2182.1% | 117,599 | +1747.3% | 1.00% | +1898.0% |
| Q4 2018 | $419,000 | -26.6% | 6,366 | -14.0% | 0.05% | -13.8% |
| Q3 2018 | $571,000 | -42.3% | 7,406 | -90.3% | 0.06% | -46.3% |
| Q2 2018 | $989,000 | +65.4% | 76,282 | +729.2% | 0.11% | +35.0% |
| Q1 2018 | $598,000 | +30.6% | 9,199 | +29.7% | 0.08% | +15.9% |
| Q4 2017 | $458,000 | -2.8% | 7,090 | -5.5% | 0.07% | -5.5% |
| Q3 2017 | $471,000 | -84.5% | 7,500 | -85.1% | 0.07% | -85.3% |
| Q2 2017 | $3,042,000 | +713.4% | 50,255 | +597.5% | 0.50% | +568.9% |
| Q1 2017 | $374,000 | +35.0% | 7,205 | +15.5% | 0.07% | +29.8% |
| Q4 2016 | $277,000 | -10.6% | 6,240 | -4.2% | 0.06% | -18.6% |
| Q3 2016 | $310,000 | -78.7% | 6,515 | -79.7% | 0.07% | -78.0% |
| Q2 2016 | $1,453,000 | +39.4% | 32,130 | +26.6% | 0.32% | +37.7% |
| Q1 2016 | $1,042,000 | +5110.0% | 25,370 | +4059.0% | 0.23% | +3750.0% |
| Q3 2015 | $20,000 | – | 610 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |